ArticleBreast cancer research : BCR2018

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Iain R Hutcheson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.